Islet amyloid: from fundamental biophysics to mechanisms of cytotoxicity
- PMID: 23380070
- PMCID: PMC3753196
- DOI: 10.1016/j.febslet.2013.01.046
Islet amyloid: from fundamental biophysics to mechanisms of cytotoxicity
Abstract
Pancreatic islet amyloid is a characteristic feature of type 2 diabetes. The major protein component of islet amyloid is the polypeptide hormone known as islet amyloid polypeptide (IAPP, or amylin). IAPP is stored with insulin in the β-cell secretory granules and is released in response to the stimuli that lead to insulin secretion. IAPP is normally soluble and is natively unfolded in its monomeric state, but forms islet amyloid in type 2 diabetes. Islet amyloid is not the cause of type 2 diabetes, but it leads to β-cell dysfunction and cell death, and contributes to the failure of islet cell transplantation. The mechanism of IAPP amyloid formation is not understood and the mechanisms of cytotoxicity are not fully defined.
Copyright © 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Figures
References
-
- Westermark P, Wernstedt C, Wilander E, Hayden DW, Obrien TD, Johnson KH. Amyloid fibrils in human insulinoma and islets of langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc. Natl. Acad. Sci. U. S. A. 1987;84:3881–3885. - PMC - PubMed
-
- Lukinius A, Wilander E, Westermark GT, Engstrom U, Westermark P. Co-localization of islet amyloid polypeptide and insulin in the beta-cell secretory granules of the human pancreatic-islets. Diabetologia. 1989;32:240–244. - PubMed
-
- Kahn SE, Dalessio DA, Schwartz MW, Fujimoto WY, Ensinck JW, Taborsky GJ, Porte D. Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes. 1990;39:634–638. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
